MIR31HG and esophageal cancer: Previous studies have shown that MIR31HG presents a carcinogenic phenotype in various solid tumors, such as PDAC, squamous cell carcinoma of the head and neck, and esophageal cancer,[44, 45, 46] while the effects of LINC01239 have rarely been reported.